Company overview
Seven Bridges provides a scalable, secure cloud-based platform for biomedical data analysis, specializing in genomics for cancer research, drug development, and precision medicine. It offers end-to-end bioinformatic solutions including datasets, analytic workflows, algorithms, cloud infrastructure, and scientific support to accelerate from raw data to treatments. The platform supports drug discovery processes like biomarker discovery, target identification, lead optimization, and clinical trial optimization, as well as clinical diagnostics with secondary NGS analysis.
Seven Bridges is listed in the NovaPharmaNews Supplier Hub in the life-science supply chain serving United States & Americas. Core focus areas include seven bridges, genomics platform, biomedical data analysis, drug discovery, precision medicine.
Structured facts
- Website
- https://www.sevenbridges.com
- Markets served
- United States & Americas
- Keywords
- seven bridges, genomics platform, biomedical data analysis, drug discovery, precision medicine
Products & technologies
Markets served
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Frequently asked questions
- What capabilities does Seven Bridges offer for drug discovery?
- The platform accelerates biomedical data analysis for biomarker discovery, target identification, lead optimization, and clinical trial optimization in a scalable, secure cloud environment.
- Is the Seven Bridges platform compliant for clinical diagnostics?
- Yes, it supports secondary NGS analysis for clinical applications, enabling diagnostic labs to streamline workflows and deliver reliable, reproducible results.
- What geographies and access methods does Seven Bridges support?
- The cloud-based platform enables secure data storage, analysis, and sharing for teams working locally and globally, accessible via visual interface or API.
Related editorial coverage
- Drug Discovery USA 2026: What to Expect
- Lunai Bioworks and BrainStorm Therapeutics Launch AI Collaboration for Parkinson's and Rare Epilepsy
- Verge Rebrands AI Drug Discovery After Trial Setback
- Streamlined R&D at Novo Nordisk: Insights from Research Chief Petersen
- BBSW AI Solution Event: Daily Roundup
- BBSW AI Solution Event: Biotech Innovation in US
Explore lab tools and QA/QC resources for R&D teams.
